human | Q5 |
P6178 | Dimensions author ID | 01146731442.23 |
P2038 | ResearchGate profile ID | Becki-Bucher-Bartelson |
P108 | employer | Denver Health Medical Center | Q3023367 |
P106 | occupation | researcher | Q1650915 |
Q34083659 | A US perspective of symptomatic Latrodectus spp. envenomation and treatment: a National Poison Data System review |
Q54078573 | A method for the standardized offline collection of exhaled nitric oxide. |
Q86054167 | A randomized, double-blind, placebo-controlled trial of a highly purified equine F(ab)2 antibody black widow spider antivenom |
Q33987828 | A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration |
Q50458050 | A single-arm clinical trial of a 48-hour intravenous N-acetylcysteine protocol for treatment of acetaminophen poisoning |
Q50458628 | Abuse and diversion of buprenorphine sublingual tablets and film |
Q39903614 | Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System |
Q40198215 | Assessment of prescription opioid intentional exposures across the rural-urban continuum in the United States using both population and drug availability rates |
Q43535688 | Assessment of the abuse of tapentadol immediate release: the first 24 months |
Q38186173 | Association of unintentional pediatric exposures with decriminalization of marijuana in the United States |
Q47878148 | Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis |
Q38652422 | Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy |
Q37479288 | Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS(®)) System |
Q43622335 | Characterization of aerosol output from various nebulizer/compressor combinations |
Q54722072 | Circadian variation in exhaled nitric oxide in nocturnal asthma. |
Q73555014 | Comparison of three commercial ultrasonic nebulizers |
Q39657340 | Do prescription monitoring programs impact state trends in opioid abuse/misuse? |
Q36580231 | Effect of therapeutic doses of acetaminophen (up to 4 g/day) on serum alanine aminotransferase levels in subjects consuming ethanol: systematic review and meta-analysis of randomized controlled trials |
Q37911893 | Impact of cardiovascular disease guideline dissemination on provider knowledge |
Q46599662 | Inpatient initiation of beta-blockade plus nurse management in vulnerable heart failure patients: a randomized study |
Q41721213 | Irritant-associated vocal cord dysfunction |
Q38834312 | Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration |
Q38097229 | Medically significant late bleeding after treated crotaline envenomation: a systematic review |
Q43685211 | Nonmedical use of tapentadol immediate release by college students |
Q36618136 | Paracetamol (acetaminophen) protein adduct concentrations during therapeutic dosing |
Q46886728 | Physician awareness of the cardiac effects of methadone: results of a national survey |
Q56888055 | Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: profiling and relation to sales data |
Q52911469 | Psychosocial competence of unselected young adults with sex chromosome abnormalities. |
Q35180735 | QTc interval screening in an opioid treatment program |
Q44161409 | Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. |
Q50194305 | Reduction in acute myocardial infarction hospitalization after implementation of a smoking ordinance |
Q39769704 | Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance |
Q38133012 | Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children |
Q44344075 | Seasonal variation in suicidal behavior with prescription opioid medication |
Q73297407 | Serum neopterin in chronic beryllium disease |
Q43527848 | Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis |
Q54378531 | The effect of a statewide smoking ordinance on acute myocardial infarction rates. |
Q88246704 | Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014 |
Q41583893 | Trends in opioid analgesic abuse and mortality in the United States |
Q44350712 | Trends in opioid analgesic abuse and mortality in the United States |
Q30629456 | Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data |
Q42244056 | Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits |
Q83962146 | Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia |
Search more.